177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
Active, not recruiting · NCT03874884 · Registry updated 2025-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Active, not recruiting | Phase 1 | 2025-05-14 | NCT03874884 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peter MacCallum Cancer Centre, Australia | 48 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| St Vincent's Hospital Sydney | Sydney | Australia | 8 |